Delivery Order SPE2DB22D2206-SPE2DB24FGA68
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,690.10, is for the delivery of SHINGRIX vial kits. This award is a delivery order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at up to $999,999,999.00 and runs through November 2026. The IDC serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,556.72 Delivery Order contract is for the delivery of SHINGRIX VIAL KITS, a pharmaceutical product, with a performance period ending on May 14, 2025. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, is a delivery order valued at $1,806.56 for the supply of SHINGRIX vial kits. The contract was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense, and has a period of performance through April 29, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,056.04 firm fixed-price delivery order is for the supply of SHINGRIX vial kits, a vaccine product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award, valued at $14,128.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of SHINGRIX vial kits, with an ultimate completion date of March 25, 2025. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,069.01 for the supply of SHINGRIX vial kits. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of September 18, 2023. The contract is a Firm Fixed Price arrangement, and there is no set-aside designation indicated. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of SHINGRIX vial kits to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $19,003.00, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through November 2026. This IDC serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,112.08 firm fixed-price delivery order is for the supply of SHINGRIX vial kits, a vaccine product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $1,696.16, is for the delivery of SHINGRIX vial kits. It is a Firm Fixed Price Delivery Order contract with an ultimate completion date of August 13, 2024. The contract is not set aside for any specific business type. Amerisourcebergen, as the prime contractor, will be...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, provides Shingrix vial kits to the Defense Logistics Agency (DLA). The $1,497.69 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract covers critical medical commodities...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FGA68Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) as a delivery order under an Indefinite Delivery Contract (IDC). The contract, valued at $12,677.46, is for the supply of SHINGRIX VIAL KITS, a medical product. The IDC held by Amerisourcebergen with the DLA is valued at $999,999,999 and runs through November 2026, serving as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and there is no mention of any major subcontractors. The DLA, as a defense agency, procures medical commodities to support the healthcare needs of military personnel and veterans.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.7k | 3/11/24 |